MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 203 filers reported holding MYRIAD GENETICS INC in Q2 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
Q4 2019 | $0 | – | 15 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $6,000 | -93.8% | 225 | -89.3% | 0.00% | -100.0% |
Q3 2018 | $96,000 | +31.5% | 2,094 | +6.9% | 0.00% | +33.3% |
Q2 2018 | $73,000 | +73.8% | 1,959 | +58.8% | 0.00% | +50.0% |
Q1 2018 | $42,000 | 0.0% | 1,234 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $42,000 | +110.0% | 1,234 | +124.8% | 0.00% | +100.0% |
Q3 2017 | $20,000 | +300.0% | 549 | +175.9% | 0.00% | – |
Q2 2017 | $5,000 | 0.0% | 199 | -17.1% | 0.00% | – |
Q1 2017 | $5,000 | +25.0% | 240 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | -77.8% | 240 | -72.4% | 0.00% | -100.0% |
Q3 2016 | $18,000 | -33.3% | 870 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $27,000 | -22.9% | 870 | +8.8% | 0.00% | 0.0% |
Q4 2015 | $35,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |